Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Gasasira, Anne F ^a,c   Kamya, Moses R ^a   Ochong, Edwin O ^b   Vora, Neil ^b   Achan, Jane ^a   Charlebois, Edwin ^b   Ruel, Theodore ^b   Kateera, Fredrick ^a   Meya, Denise N ^a   Havlir, Diane ^b   Rosenthal, Philip J ^b   Dorsey, Grant ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; EFAVIRENZ; FANSIDAR; FOLIC ACID ANTAGONIST; INSECTICIDE; LAMIVUDINE; ZIDOVUDINE; ANTIMALARIAL AGENT;

ARTICLE; BED NET; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA POLYMORPHISM; DRUG EFFICACY; DRUG WITHDRAWAL; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NEUTROPENIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; UGANDA; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; INFANT; MALE; METABOLISM; MUTATION; PARASITOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR; TREATMENT OUTCOME;

ANTIMALARIALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; FOLIC ACID ANTAGONISTS; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INSECTICIDE-TREATED BEDNETS; MALARIA, FALCIPARUM; MALE; MUTATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; TETRAHYDROFOLATE DEHYDROGENASE; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UGANDA;

EID: 77953692027     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-177     Document Type: Article

References (32)

1. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cte d'Ivoire: a randomised trial. Cotrimo-CI Study Group. X Anglaret G Chene A Attia S Toure S Lafont P Combe K Manlan T N'Dri-Yoman R Salamon, Lancet 1999 353 1463 1468 10.1016/S0140-6736(98)07399-1 10232311
2. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cte d'Ivoire: a randomised controlled trial. SZ Wiktor M Sassan-Morokro AD Grant L Abouya JM Karon C Maurice G Djomand A Ackah K Domoua A Kadio A Yapi P Combe O Tossou TH Roels EM Lackritz D Coulibaly KM De Cock IM Coulibaly AE Greenberg, Lancet 1999 353 1469 1475 10.1016/S0140-6736(99)03465-0 10232312
3. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. J Mermin JP Ekwaru CA Liechty W Were R Downing R Ransom P Weidle J Lule A Coutinho P Solberg, Lancet 2006 367 1256 1261 10.1016/S0140-6736(06)68541-3 16631881
4. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. MR Kamya AF Gasasira J Achan T Mebrahtu T Ruel A Kekitiinwa ED Charlebois PJ Rosenthal D Havlir G Dorsey, AIDS 2007 21 2059 2066 10.1097/QAD.0b013e3282ef6da1 17885296
5. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. MA Thera PS Sehdev D Coulibaly K Traore MN Garba Y Cissoko A Kone A Guindo A Dicko A Beavogui AA Djimde KE Lyke DA Diallo OK Doumbo CV Plowe, J Infect Dis 2005 192 1823 1829 10.1086/498249 16235184
6. WHO, Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Recommendations for a public health approach 2006 http://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf
7. WHO UU, Children and AIDS: a stocktaking report 2007 2007 http://data.unaids.org/pub/report//2007/20060116-stocktaking-report.pdf
8. Drugs for preventing malaria in pregnant women. P Garner AM Gulmezoglu, Cochrane Database Syst Rev 2006 D000169 17054128
9. Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment. JC Davis TD Clark SK Kemble N Talemwa D Njama-Meya SG Staedke G Dorsey, Malar J 2006 5 18 10.1186/1475-2875-5-18 16551365
10. Ministry of Health U, Uganda National Antiretroviral Treatment and Care Guidelines for Adults and Children 2003
11. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. AF Gasasira MR Kamya J Achan T Mebrahtu JN Kalyango T Ruel E Charlebois SG Staedke A Kekitiinwa PJ Rosenthal D Havlir G Dorsey, Clin Infect Dis 2008 46 985 991 10.1086/529192 18444813
12. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. G Snounou S Viriyakosol XP Zhu W Jarra L Pinheiro VE do Rosario S Thaithong KN Brown, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
13. Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. B Greenhouse A Myrick C Dokomajilar JM Woo EJ Carlson PJ Rosenthal G Dorsey, Am J Trop Med Hyg 2006 75 836 842 17123974
14. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. CV Plowe A Djimde M Bouare O Doumbo TE Wellems, Am J Trop Med Hyg 1995 52 565 568 7611566
15. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. MT Duraisingh J Curtis DC Warhurst, Exp Parasitol 1998 89 1 8 10.1006/expr.1998.4274 9603482
16. Mechanisms of resistance of malaria parasites to antifolates. A Gregson CV Plowe, Pharmacol Rev 2005 57 117 145 10.1124/pr.57.1.4 15734729
17. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. M Ndounga R Tahar LK Basco PN Casimiro DA Malonga F Ntoumi, Trop Med Int Health 2007 12 1164 1171 17956498
18. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy Plasmodium falciparumdihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. K Mugittu M Ndejembi A Malisa M Lemnge Z Premji A Mwita W Nkya J Kataraihya S Abdulla HP Beck H Mshinda, Am J Trop Med Hyg 2004 71 696 702 15642957
19. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. TD Swarthout IV van den Broek G Kayembe J Montgomery H Pota C Roper, Trop Med Int Health 2006 11 1503 1511 10.1111/j.1365-3156.2006.01710.x 17002724
20. Prediction of Plasmodium falciparum resistance to sulfadoxine/ pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity. M Alifrangis S Enosse IF Khalil DS Tarimo MM Lemnge R Thompson IC Bygbjerg AM Ronn, Am J Trop Med Hyg 2003 69 601 606 14740875
21. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? CH Sibley JE Hyde PF Sims CV Plowe JG Kublin EK Mberu AF Cowman PA Winstanley WM Watkins AM Nzila, Trends Parasitol 2001 17 582 588 10.1016/S1471-4922(01) 02085-2 11756042
22. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? A Nzila E Ochong E Nduati K Gilbert P Winstanley S Ward K Marsh, Trans R Soc Trop Med Hyg 2005 99 341 346 10.1016/j.trstmh.2004.07.002 15780340
23. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. FO ter Kuile AM van Eijk SJ Filler, JAMA 2007 297 2603 2616 10.1001/jama.297.23.2603 17579229
24. Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi). R Kobbe S Adjei C Kreuzberg B Kreuels B Thompson PA Thompson F Marks W Busch M Tosun N Schreiber E Opoku O Adjei CG Meyer J May, Malar J 2007 6 163 10.1186/1475-2875-6-163 18067679
25. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. D Francis SL Nsobya A Talisuna A Yeka MR Kamya R Machekano C Dokomajilar PJ Rosenthal G Dorsey, J Infect Dis 2006 193 978 986 10.1086/500951 16518760
26. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. AM McCollum AC Poe M Hamel C Huber Z Zhou YP Shi P Ouma J Vulule P Bloland L Slutsker JW Barnwell V Udhayakumar AA Escalante, J Infect Dis 2006 194 189 197 10.1086/504687 16779725
27. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. AP Alker V Mwapasa A Purfield SJ Rogerson ME Molyneux DD Kamwendo E Tadesse E Chaluluka SR Meshnick, Antimicrob Agents Chemother 2005 49 3919 3921 10.1128/AAC.49.9.3919- 3921.2005 16127071
28. Emergence of a dhfr Mutation Conferring High-Level Drug Resistance in Plasmodium falciparum Populations from Southwest Uganda. C Lynch R Pearce H Pota J Cox TA Abeku J Rwakimari I Naidoo J Tibenderana C Roper, J Infect Dis 2008 197 1598 1604 10.1086/587845 18471065
29. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. WM Watkins EK Mberu PA Winstanley CV Plowe, Parasitol Today 1997 13 459 464 10.1016/S0169-4758(97)01124-1 15275132
30. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. DR Brooks P Wang M Read WM Watkins PF Sims JE Hyde, Eur J Biochem 1994 224 397 405 10.1111/j.1432-1033. 1994.00397.x 7925353
31. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. AM McCollum K Mueller L Villegas V Udhayakumar AA Escalante, Antimicrob Agents Chemother 2007 51 2085 2091 10.1128/AAC.01228-06 17283199
32. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. S Gesase RD Gosling R Hashim R Ord I Naidoo R Madebe JF Mosha A Joho V Mandia H Mrema E Mapunda Z Savael M Lemnge FW Mosha B Greenwood C Roper D Chandramohan, PLoS One 2009 4 4569 10.1371/journal.pone.0004569 19238219